Press Release

Global Genomics Market Size, Share, Industry Analysis, Trends, Demand, Growth Opportunity, Regional Outlook, & Forecast 2018-2026

Genomics Market Size, Demand, Share, Industry Analysis, Regional Outlook, Trends, And Forecast 2019-2026

Genomics Market is most commonly used for the diagnosis of cancer. Recent advancements in personalized medicine and genomics have bought significant transformations in disease management. The growing use of genomics in several clinical trials is reflecting a growing trend. Consequently, The Global Genomics Market is expected to rise at an exponential CAGR of 18.7% between 2018 and 2026. In 2018, the market was valued at US$ 15,888.8 Mn and it is anticipated to reach US$ 62,614.6 Mn by 2026.

Get PDF Brochure of this [email protected]

Key questions answered in the Genomics Market report:

  • What will the market growth rate of Genomics market in 2026?
  • What are the key factors driving the Global Genomics market?
  • What are sales, revenue, and price analysis of top manufacturers of Genomics market?
  • Who are the distributors, traders and dealers of Genomics market?
  • Who are the key vendors in Genomics market space?
  • What are the Genomics market opportunities and threats faced by the vendors in the Asia Genomics market?

Veritas Genetics Launched myGenome to Offer Personalized Services to its Customers

General Electric Company, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Agilent Technologies, Inc., IntegraGen, QIAGEN, BGI, F. Hoffmann-La Roche Ltd, Danaher, and Illumina, Inc. are some of the leading players in the global genomics market. Among these, F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., and Illumina, Inc. are projected to dominate the global market. Strong geographical presence and robust portfolio are factors responsible for their prominent position in the market. Several companies are entering into strategic alliances to better their market position and increase revenue. Bristol Myers Squibb collaborated with Foundation Medicine in March 2017. This collaboration will help the former company to leverage the latter’s molecular information and genomic profiling solutions. Furthermore, it will help Bristol Myers to identify biomarkers such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB) in cancer patients. Another company called 10X Genomics acquired an epigenomics-based startup called Epinomics in August 2018. This acquisition will help the company strengthen its market position.

Key players leading the Global Genomics Market include

  • Thermo Fisher Scientific Inc.,
  • Oxford Nanopore Technologies,
  • Agilent Technologies, Inc.,
  • IntegraGen,
  • BGI
  • Danaher,
  • Illumina, Inc.,
  • Hoffmann-La Roche Ltd,
  • include Next-generation Sequencing (NGS),
  • Sanger sequencing,
  • Polymerase Chain Reactions (PCR)

Order Complete [email protected]

A Myriad of R&D Activities Has Spurred Growth Prospects for Genomics Market

“Several services and start-up companies are paving their way into genomics industry by offering services which include ancestry services, direct-to-customer genomic services, among others,” stated a lead analyst at Fortune Business Insights. “Rising support from governments regarding research and funding is expected to contribute to the growth of the market,” he added. Several genomic institutes are supporting the industry by granting funds for performing research and development activities. Stanford healthcare uses genomic information to develop a personalized treatment for patients suffering from chronic illness.

More Trending Topics From Fortune Business [email protected]

Medical Imaging Equipment Market Value to Exceed USD 44,077.7 Mn by 2025

Regenerative Medicine Market Stand Out as the Biggest Contributor to Global Growth and Will Hit 26.1% CAGR By 2026


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *